These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7890335)

  • 1. Differences in the disposition and toxicity of 1-methyl-4-phenylpyridinium in cultured rat and mouse astrocytes.
    Tsai MJ; Lee EH
    Glia; 1994 Dec; 12(4):329-35. PubMed ID: 7890335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes.
    Di Monte DA; Wu EY; Delanney LE; Irwin I; Langston JW
    J Pharmacol Exp Ther; 1992 Apr; 261(1):44-9. PubMed ID: 1560384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse astrocytes.
    Di Monte DA; Wu EY; Irwin I; Delanney LE; Langston JW
    Glia; 1992; 5(1):48-55. PubMed ID: 1311704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of the 1-methyl-4-phenyl-2,3-dihydropyridinium and 1-methyl-4-phenylpyridinium species in primary cultures of mouse astrocytes.
    Wu EY; Langston JW; Di Monte DA
    J Pharmacol Exp Ther; 1992 Jul; 262(1):225-30. PubMed ID: 1625201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes.
    Di Monte DA; Wu EY; Irwin I; Delanney LE; Langston JW
    J Pharmacol Exp Ther; 1991 Aug; 258(2):594-600. PubMed ID: 1907660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice.
    Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK
    J Pharmacol Exp Ther; 1991 May; 257(2):691-7. PubMed ID: 2033514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium.
    Giovanni A; Sonsalla PK; Heikkila RE
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1008-14. PubMed ID: 7932148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical and toxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridine to rat serotonin neurons in dissociated cell cultures.
    Friedman LK; Mytilineou C
    J Pharmacol Exp Ther; 1990 May; 253(2):892-8. PubMed ID: 2338661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
    Zuddas A; Fascetti F; Corsini GU; Piccardi MP
    Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.
    Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1000-7. PubMed ID: 7932147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons.
    Johannessen JN
    Neurotoxicology; 1991; 12(2):285-302. PubMed ID: 1956587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures.
    Di Monte DA; Schipper HM; Hetts S; Langston JW
    Glia; 1995 Oct; 15(2):203-6. PubMed ID: 8567072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
    Otto D; Unsicker K
    J Neurosci Res; 1993 Mar; 34(4):382-93. PubMed ID: 8097265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B).
    Ito T; Suzuki K; Uchida K; Nakayama H
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):153-8. PubMed ID: 21855308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired glutamate clearance as a consequence of energy failure caused by MPP(+) in astrocytic cultures.
    Di Monte DA; Tokar I; Langston JW
    Toxicol Appl Pharmacol; 1999 Aug; 158(3):296-302. PubMed ID: 10438663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
    Staal RG; Sonsalla PK
    J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver.
    Riachi NJ; Harik SI; Kalaria RN; Sayre LM
    J Pharmacol Exp Ther; 1988 Feb; 244(2):443-8. PubMed ID: 3258032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity of 1-amino-4-phenyl-1,2,3,6-tetrahydropyridine and 1-amino-4-phenylpyridinium ion, 1-amino analogues of MPTP and MPP+, to clonal pheochromocytoma PC12 cells.
    Kohda K; Noda Y; Aoyama S; Umeda M; Sumino T; Kaiya T; Maruyama W; Naoi M
    Chem Res Toxicol; 1998 Nov; 11(11):1249-53. PubMed ID: 9815183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocytes as the site for bioactivation of neurotoxins.
    Di Monte DA; Royland JE; Irwin I; Langston JW
    Neurotoxicology; 1996; 17(3-4):697-703. PubMed ID: 9086491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenylpiridinium (MPP(+)) converted from MPTP through MAO-B.
    Ito T; Suzuki K; Uchida K; Nakayama H
    Exp Toxicol Pathol; 2012 Nov; 64(7-8):761-5. PubMed ID: 21324658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.